Skip to main content

Table 1 Metabolic syndrome definitions provided by various authorities

From: Visceral adiposity syndrome

Authority, yr WHO 1998 EGIR 1999 ATP III (2001/4) IDF 2005
Insulin resistance IGT, IFG, T2D; insulin resistance + 2 below Plasma insulin >75th percentile + 2 below None; any 3 of the 5 below None
BMI or body fat distribution Men WHR >0.90
Women WHR >0.85 or BMI >30
WC ≥94 cm men or ≥80 cm women WC >102 cm men or >88 cm women Increased WC (pop. specific) + 2 below
Lipids TG ≥150 mg/dL
HDL <35 men or <39 women
TG ≥ 150 mg/dL
HDL <39 in men or women
TG ≥150 mg/dL
HDL <40 men or <50 women
TG ≥150 mg/dL or Rx, HDL <40 men or <50 women or Rx
Glucose IGT, IFG, T2D IGT or IFG ≥110 mg/dL ≥100 mg/dL or diabetes
Blood pressure ≥140/≥90 ≥140/≥90 or Htn Rx ≥130/≥85 ≥130/≥85 or Htn Rx
Other Urine alb >20 mg /min; ACR >30 mg/g    
  1. WHO World Health Organization, EGIR European Group for the study of Insulin resistance, ATP adult treatment panel, IDF international diabetes federation, IGT impaired glucose tolerance, IFG impaired fasting glucose, T2D type 2 diabetes, BMI body mass index, WHR waist:hip ratio, Htn hypertension, Rx pharmacologic treatment, alb albumin, ACR albumin:creatinine ratio